- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03483623
NATO Litter: Fluid Immersion System (FIS) Versus Traditional Mattress for Pressure Dispersion
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The purpose of this study is to measure peak skin interface pressures and the total area of the body exposed to skin interface pressure above 30 mm Hg at different areas of the body in the supine position on two different support surfaces applied to a standard North Atlantic Treaty Organization (NATO) litter (NSN: 6530-01-380-7309) and a Raven 90C Litter (NSN6530-01-432-5114). The Raven 90C is the official litter for the U.S. Navy. It is approved for flight on United States Air Force (USAF) aircraft. It can be easily folded for storage and transport to remote settings. The support surfaces are the Warrior Evacuation Litter Pad (WELP) and the Dolphin Fluid Immersion Simulation Stretcher System (FIS). In theory, mattresses that reduce and/or minimize pressure on the capillary bed's perfusion can help reduce pressure related injury such as pressure or decubitus ulcer development. Skin interface pressure measurements using a pressure mapping system and transcutaneous oxygenation readings will allow us to determine these differences between support surfaces. A better understanding of skin interface pressure associated with the litter support surfaces is vital for military nurses to develop and implement preventative interventions to reduce pressure ulcer development in our patients. In addition, this study will provide information to help determine the usefulness and feasibility of incorporating the fluid immersion system (FIS) as a litter support surface.
This research protocol has one major aim:
To determine the difference in the pressure redistribution qualities between the WELP and the Dolphin FIS
There are also two secondary aims:
- To determine the difference in the pressure redistribution qualities of the WELP when used as the mattress on the NATO litter and Raven litter.
- To determine the difference in the pressure redistribution qualities of the Dolphin FIS when used as the mattress on the NATO litter and Raven litter.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
Travis Air Force Base, California, United States, 94535
- David Grant Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adults over the age of 18 years with lawful access to Travis Air Force Base (AFB)
Exclusion Criteria:
- Orthopedic or neurological conditions that prevent a subject from lying flat (supine) without any pillows for head, neck, or lumbar support
- Medical conditions (such as an uncontrollable tremor or twitch) that prevent a subject from staying still for the required periods of time (20 minute increments).
- Pregnancy
- Inability to ambulate unassisted, unstable gate (presenting increased fall risk)
- Extremity prosthetics (hand/arm or foot/leg)
- Height greater than 72 inches (6 feet) - exceeds length of the litter & mattress surfaces
- Body weight greater than 300 lbs
- Subjects who find it difficult, uncomfortable or impossible to remain still for the necessary study time durations (20 minute increments) on the relatively narrow litter surfaces will be removed from the study.
- Subject does not speak or understand the English language
Study Plan
How is the study designed?
Design Details
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Allocation: NON_RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: NATO WELP combination
Subjects will be their own control and have repeated measurements to compare baseline and supine transcutaneous oxygenation levels and interface pressures on NATO litter and WELP mattress combination
|
Interface pressure will be measured using the XSensor X3 Pressure Mapping System.
Transducers will be placed near both scapula.
Measures will be obtained in upright (baseline) and supine positions on 4 randomly assigned litter mattress combinations.
Constant TCPO2 measures, as well as peak pressures and total body surface area exposed to skin will be measured for the occiput, sacrum, both scapula, buttocks and heel areas.
It will take about 20 minutes for each combination.
The session is complete after all measures have been obtain for all litter/mattress combinations.
|
EXPERIMENTAL: NATO FIS combination
Subjects will be their own control and have repeated measurements to compare baseline and supine transcutaneous oxygenation levels and interface pressures on NATO litter and Fluid Immersion System (FIS) mattress combination
|
Interface pressure will be measured using the XSensor X3 Pressure Mapping System.
Transducers will be placed near both scapula.
Measures will be obtained in upright (baseline) and supine positions on 4 randomly assigned litter mattress combinations.
Constant TCPO2 measures, as well as peak pressures and total body surface area exposed to skin will be measured for the occiput, sacrum, both scapula, buttocks and heel areas.
It will take about 20 minutes for each combination.
The session is complete after all measures have been obtain for all litter/mattress combinations.
|
EXPERIMENTAL: RAVEN WELP combination
Subjects will be their own control and have repeated measurements to compare baseline and supine transcutaneous oxygenation levels and interface pressures on Raven 90C litter and WELP mattress combination
|
Interface pressure will be measured using the XSensor X3 Pressure Mapping System.
Transducers will be placed near both scapula.
Measures will be obtained in upright (baseline) and supine positions on 4 randomly assigned litter mattress combinations.
Constant TCPO2 measures, as well as peak pressures and total body surface area exposed to skin will be measured for the occiput, sacrum, both scapula, buttocks and heel areas.
It will take about 20 minutes for each combination.
The session is complete after all measures have been obtain for all litter/mattress combinations.
|
EXPERIMENTAL: RAVEN FIS combination
Subjects will be their own control and have repeated measurements to compare baseline and supine transcutaneous oxygenation levels and interface pressures on Raven 90C litter and Fluid Immersion System (FIS) mattress combination
|
Interface pressure will be measured using the XSensor X3 Pressure Mapping System.
Transducers will be placed near both scapula.
Measures will be obtained in upright (baseline) and supine positions on 4 randomly assigned litter mattress combinations.
Constant TCPO2 measures, as well as peak pressures and total body surface area exposed to skin will be measured for the occiput, sacrum, both scapula, buttocks and heel areas.
It will take about 20 minutes for each combination.
The session is complete after all measures have been obtain for all litter/mattress combinations.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pressure Redistribution: Peak Pressure Index
Time Frame: 0 minutes
|
Determine the difference in the pressure redistribution qualities between the WELP and the Dolphin FIS when used as mattress on the NATO litter and Raven litter.
Pressure redistribution qualities will be measured in mmHg using XSensor X3 pressure mapping technology.
To minimize the risk of a faulty sensor or false reading over one sensor, the average of eight cells around the region will be recorded and referred to as the Peak Pressure Index (PPI).
Peak interface pressure is the highest average pressure (mm Hg) measured over vulnerable bony prominences (occiput, sacrum, and bilateral scapula, buttocks, and heels) at 0 minutes.
PPI will be measured in mm Hg and the mean will be reported
|
0 minutes
|
Pressure Redistribution: Peak Pressure Index
Time Frame: 5 minutes
|
Determine the difference in the pressure redistribution qualities between the WELP and the Dolphin FIS when used as mattress on the NATO litter and Raven litter.
Pressure redistribution qualities will be measured in mmHg using XSensor X3 pressure mapping technology.
To minimize the risk of a faulty sensor or false reading over one sensor, the average of eight cells around the region will be recorded and referred to as the Peak Pressure Index (PPI).
Peak interface pressure is the highest average pressure (mm Hg) measured over vulnerable bony prominences (occiput, sacrum, and bilateral scapula, buttocks, and heels) at 5 minutes.
PPI will be measured in mm Hg and the mean will be reported
|
5 minutes
|
Pressure Redistribution: Peak Pressure Index
Time Frame: 10 minutes
|
Determine the difference in the pressure redistribution qualities between the WELP and the Dolphin FIS when used as mattress on the NATO litter and Raven litter.
Pressure redistribution qualities will be measured in mmHg using XSensor X3 pressure mapping technology.
To minimize the risk of a faulty sensor or false reading over one sensor, the average of eight cells around the region will be recorded and referred to as the Peak Pressure Index (PPI).
Peak interface pressure is the highest average pressure (mm Hg) measured over vulnerable bony prominences (occiput, sacrum, and bilateral scapula, buttocks, and heels) at 10 minutes.
PPI will be measured in mm Hg and the mean will be reported
|
10 minutes
|
Pressure Redistribution: Peak Pressure Index
Time Frame: 15 minutes
|
Determine the difference in the pressure redistribution qualities between the WELP and the Dolphin FIS when used as mattress on the NATO litter and Raven litter.
Pressure redistribution qualities will be measured in mmHg using XSensor X3 pressure mapping technology.
To minimize the risk of a faulty sensor or false reading over one sensor, the average of eight cells around the region will be recorded and referred to as the Peak Pressure Index (PPI).
Peak interface pressure is the highest average pressure (mm Hg) measured over vulnerable bony prominences (occiput, sacrum, and bilateral scapula, buttocks, and heels) at 15 minutes.
PPI will be measured in mm Hg and the mean will be reported
|
15 minutes
|
Pressure Redistribution: Total Surface Area (TSA) > 30 mm Hg
Time Frame: 0 minutes
|
Determine the difference in the pressure redistribution qualities between the WELP when used on the NATO litter and Raven litter.
Pressure redistribution will be measured over vulnerable bony prominences as total area of body exposed to skin interface pressures exceeding 30 mm Hg while subjects are in the supine position at 0 minutes.
This measure will be expressed as cm2 and the mean will be reported
|
0 minutes
|
Pressure Redistribution: Total Surface Area (TSA) > 30 mm Hg
Time Frame: 5 minutes
|
Determine the difference in the pressure redistribution qualities between the WELP when used on the NATO litter and Raven litter.
Pressure redistribution will be measured over vulnerable bony prominences as total area of body exposed to skin interface pressures exceeding 30 mm Hg while subjects are in the supine position at 5 minutes.
This measure will be expressed as cm2 and the mean will be reported
|
5 minutes
|
Pressure Redistribution: Total Surface Area (TSA) > 30 mm Hg
Time Frame: 10 minutes
|
Determine the difference in the pressure redistribution qualities between the WELP when used on the NATO litter and Raven litter.
Pressure redistribution will be measured over vulnerable bony prominences as total area of body exposed to skin interface pressures exceeding 30 mm Hg while subjects are in the supine position at 10 minutes.
This measure will be expressed as cm2 and the mean will be reported
|
10 minutes
|
Pressure Redistribution: Total Surface Area (TSA) > 30 mm Hg
Time Frame: 15 minutes
|
Determine the difference in the pressure redistribution qualities between the WELP when used on the NATO litter and Raven litter.
Pressure redistribution will be measured over vulnerable bony prominences as total area of body exposed to skin interface pressures exceeding 30 mm Hg while subjects are in the supine position at 15 minutes.
This measure will be expressed as cm2 and the mean will be reported
|
15 minutes
|
Collaborators and Investigators
Investigators
- Principal Investigator: Laurie Migliore, PhD, David Grant Medical Center
- Principal Investigator: Antoinette Shinn, PhD, 59th Medical Wing
Publications and helpful links
General Publications
- Bale S, Finlay I, Harding KG. Pressure sore prevention in a hospice. J Wound Care. 1995 Nov;4(10):465-8. doi: 10.12968/jowc.1995.4.10.465.
- Bridges EJ, Schmelz JO, Mazer S. Skin interface pressure on the NATO litter. Mil Med. 2003 Apr;168(4):280-6.
- Hanson DS, Langemo D, Anderson J, Thompson P, Hunter S. Can pressure mapping prevent ulcers? Nursing. 2009 Jun;39(6):50-1. doi: 10.1097/01.NURSE.0000352337.67771.e0. No abstract available.
- International review. Pressure ulcer prevention: pressure, shear, friction and microclimate in context. A consensus document. London: Wounds International, 2010
- Hatzfeld JJ, Dukes S, Bridges E. Chapter 3 innovations in the en route care of combat casualties. Annu Rev Nurs Res. 2014;32:41-62. doi: 10.1891/0739-6686.32.41.
- Harada C, Shigematsu T, Hagisawa S. The effect of 10-degree leg elevation and 30-degree head elevation on body displacement and sacral interface pressures over a 2-hour period. J Wound Ostomy Continence Nurs. 2002 May;29(3):143-8. doi: 10.1067/mjw.2002.123645.
- Junkin J, Gray M. Are pressure redistribution surfaces or heel protection devices effective for preventing heel pressure ulcers? J Wound Ostomy Continence Nurs. 2009 Nov-Dec;36(6):602-8. doi: 10.1097/WON.0b013e3181be282f.
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- FDG20160005H
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Tissue Perfusion
-
Johann Wolfgang Goethe University HospitalUnknown
-
Szeged UniversityDepartment of Oral and Maxillofacial Surgery, University of Szeged; Institute...CompletedOptimal Tissue PerfusionHungary
-
Zonguldak Bulent Ecevit UniversityCompletedUpper Extremity Fracture | Regional Anesthesia | Brachial Plexus Blocks | Perfusion Index | Tissue PerfusionTurkey
-
Technical University of MunichUnknown
-
University of ZurichTerminatedCT Perfusion and MRI Perfusion in Solid TumorsSwitzerland
-
Rigshospitalet, DenmarkRadiometer Medical ApSCompletedMicrocirculation | Peripheral Perfusion | Transcutaneous Monitoring | Tissue MetabolismDenmark
-
Shanglei LiuRecruitingPerfusion; ComplicationsUnited States
-
Saint Petersburg State University, RussiaShandong Linglong Yingcheng HospitalRecruiting
-
Second Affiliated Hospital, School of Medicine,...RecruitingPerfusion; ComplicationsChina
Clinical Trials on NATO WELP combination
-
The First Affiliated Hospital of Hunan University...UnknownDiabetes Complications | Gastroparesis
-
The First Affiliated Hospital of Hunan University...University of British Columbia; Ministry of Science and Technology of the People´s...UnknownSleep Initiation and Maintenance DisordersChina
-
Virginia Commonwealth UniversityGilead SciencesWithdrawnChronic Lymphocytic Leukemia | Refractory Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | CLL | Refractory Small Lymphocytic Lymphoma | SLL | Relapsed CLL | Relapsed Chronic Lymphocytic Leukemia | Relapsed Small Lymphocytic Lymphoma
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan
-
Kaohsiung Medical University Chung-Ho Memorial...Completed
-
Hospital de Clinicas de Porto AlegreCompletedComplication of CABGBrazil
-
The Hong Kong Polytechnic UniversityCompleted
-
University Hospital, Clermont-FerrandSTENDO, 17 rue du port 27400 LOUVIERSCompleted
-
Kaohsiung Veterans General Hospital.Completed
-
Riphah International UniversityRecruiting